<DOC>
	<DOCNO>NCT02715700</DOCNO>
	<brief_summary>This study evaluate effect multiple dos MK-1439 ( doravirine ) pharmacokinetics methadone participant require methadone maintenance therapy . The primary hypothesis Area Under Concentration-Time curve 24 hour ( AUC0-24 ) ( R ) -methadone similar maintenance regimen methadone administer without multiple daily dose MK-1439 .</brief_summary>
	<brief_title>A Study Evaluate Effects Multiple Doses MK-1439 ( Doravirine ) Pharmacokinetics Methadone Participants Requiring Methadone Maintenance Therapy ( MK-1439-045 )</brief_title>
	<detailed_description />
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Methadone</mesh_term>
	<criteria>If female reproductive potential : must demonstrate serum βhuman chorionic gonadotropin ( β hCG ) level consistent nongravid state agree use ( and/or partner use ) two acceptable method birth control throughout trial 2 week last dose trial drug . If postmenopausal female : must without menses least 1 year . If surgically sterile female : must status post hysterectomy , oophorectomy tubal ligation . Body Mass Index ( BMI ) 1835 kg/m^2 ( inclusive ) . Able comply smoke restriction , include &lt; =10 cigarette per day Clinical Research Unit , smoke 2 hour predose 2 hour postdose Days 1 6 . Reliably participate methadone maintenance program least two month prior Day 1 . Required document stable dose methadone least 14 day prior Day 1 . Agree change current maintenance methadone dose 20200 mg daily ( unless safety reason ) screen end study . Must agree observation documentation daily methadone dose administration period study domicile . Mentally legally incapacitate , significant emotional problem time pretrial ( screen ) visit expect conduct trial history clinically significant psychiatric disorder last 5 year . Participants situational depression may enrol trial discretion investigator . History clinically significant endocrine , gastrointestinal , cardiovascular , hematological , hepatic , immunological , renal , respiratory , genitourinary major neurological ( include stroke chronic seizure ) abnormality diseases . Participants history uncomplicated kidney stone childhood asthma may enrol trial discretion investigator . History cancer ( malignancy ) exception apply . History significant multiple and/or severe allergy ( e.g . food , drug , latex allergy ) , anaphylactic reaction significant intolerability prescription nonprescription drug food . Positive Human Immunodeficiency Virus ( HIV ) . Major surgery , donate lose 1 unit blood ( approximately 500 mL ) within 4 week prior pretrial ( screen ) visit . Participated another investigational trial within 4 week prior pretrial ( screen ) visit . Nursing mother . Unable refrain anticipates use medication , include prescription nonprescription drug herbal remedy begin approximately 2 week prior first dose 14 day methadone maintenance phase prior Day 1 , throughout trial , posttrial visit exception apply . Consumes great 3 glass alcoholic beverage ( 1 glass approximately equivalent : beer [ 354 mL/12 ounce ] , wine [ 118 mL/4 ounce ] , distilled spirit [ 29.5 mL/1 ounce ] ) per day exception apply . Consumes excessive amount caffeine , define great 6 serving ( 1 serve approximately equivalent 120 mg caffeine ) coffee , tea , cola , energydrinks , caffeinated beverage per day . Has positive screen drug high potential abuse cocaine , amphetamine , methylenedioxymethamphetamine ( MDMA ) , barbiturates , benzodiazepine ( exception apply ) , opiates/opioids ( apart methadone assign maintenance therapy ) Day 1 explain concomitant medication , unless discretion principal investigator sponsor . Must negative Urine Drug Screen prior randomization , exception tetrahydrocannabinol ( THC ) prescription benzodiazepine . Clinical Opiate Withdrawal Scale ( COWS ) score &gt; =5 prior randomization .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>